Romosozumab Use and Cardiovascular Events

被引:4
作者
Fusaro, Maria [1 ,2 ]
Tripepi, Giovanni [3 ]
机构
[1] Natl Res Council CNR, Inst Clin Physiol IFC, Pisa, Italy
[2] Univ Padua, Dept Med, Padua, Italy
[3] Natl Res Council CNR, Inst Clin Physiol IFC, Sect Biostat, Reggio Di Calabria, Italy
关键词
D O I
10.1002/jbmr.4695
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:452 / 453
页数:2
相关论文
共 2 条
[1]   When does a difference make a difference? Interpretation of number needed to treat, number needed to harm, and likelihood to be helped or harmed [J].
Citrome, L. ;
Ketter, T. A. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2013, 67 (05) :407-411
[2]   Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild-to-Moderate Chronic Kidney Disease [J].
Miller, Paul D. ;
Adachi, Jonathan D. ;
Albergaria, Ben-Hur ;
Cheung, Angela M. ;
Chines, Arkadi A. ;
Gielen, Evelien ;
Langdahl, Bente L. ;
Miyauchi, Akimitsu ;
Oates, Mary ;
Reid, Ian R. ;
Santiago, Norma Ruiz ;
Vanderkelen, Mark ;
Wang, Zhenxun ;
Yu, Zhigang .
JOURNAL OF BONE AND MINERAL RESEARCH, 2022, 37 (08) :1437-1445